Cargando…
Osteoporosis /
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis researc...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston :
Elsevier Academic Press,
©2008.
|
| Edición: | 3rd ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- The bone organ system: form and function
- The nature of osteporosis
- The economics of osteoporosis
- Reflections on osteoporosis
- Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteporosis
- Osteoblast biology
- Osteoclast biology
- Osteocytes
- The regulatory role of matrix proteins in mineralization of bone
- Development of the skeleton
- Mouse genetics as a tool to study bone development and physiology
- Parathyroid hormone and parathyroid hormone-related protein
- Vitamin D: biology, action, and clinical implications
- Regulation of bone cell function by estrogens
- Androgens and skeletal biology: basic mechanisms
- Phosphatonins
- Wnt Signaling in bone
- Cytokins and bone remodeling
- Skeletal growth factors
- Intercellular communication during bone remodeling
- Skeletal development: mechanical consequences of growth, aging, and disease
- Inhibition of osteoporosis by biophysical intervention
- Biomechanics of age-related fractures
- Bone quality
- Epidemiologic methods in studies of osteoporosis
- Race, ethnicity and osteoporosis
- The study of osteoporotic fractures: major findings and contributions
- Bone mineral acquisition In Utero and during infancy and childhood
- Bone acquisition in adolescence
- Genetic determinants of osteoporosis
- Nutrition and risk for osteoporosis
- Physical activity in prevention of osteoporosis and associated fractures
- Premenopausal reproductive and hormonal characteristics and the risk for osteoporosis
- Nonskeletal risk factors for osteoporosis and fractures
- Falls as risk factors for fracture
- Assessment of fracture risk
- Outcomes of osteoporotic fractures
- Local and systemic factors in the pathogenesis of osteoporosis
- Animal models for osteoporosis
- Estrogen, bone homeostasis, and osteoporosis
- Postmenopausal osteoporosis: how the hormonal changes of menopause cause bone loss
- Osteoporosis in men: epidemiology, pathophysiology, and clinical characterization
- Osteoporosis in childhood and adolescence.
- Glucocorticoid-induced osteoporosis
- Adult scoliosis, degenerative disease, and BMD: a subsegmental analytic approach
- Mechanisms of immobilization-induced bone loss
- Leptin-dependent regulation of bone mass
- Thyroid hormone and the skeleton
- Osteoporosis in gastrointestinal, pancreatic, and hepatic diseases
- The skeletal actions of parathyroid hormone in primary hyperparathyroidism and in osteoporosis
- Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis
- Osteoporosis associated with illnesses and medications
- Transplantation osteoporosis
- Osteoporosis associated with cancer therapy
- Osteoporosis associated with pregnancy
- Osteoporosis associated with rheumatologic disorders
- Oral bone loss and systemic osteopenia: potential treatment and risks
- Localized osteoporosis
- Evaluation of the patient with osteoporosis or at risk for osteoporosis
- Who should be screened: who should be treated?
- Radiology of osteoporosis
- Clinical use of bone densitometry
- Biochemical markers of bone turnover in osteoporosis
- The conundrum of compliance and persistence with oral biophosphonates for postmenopausal osteoporosis
- An orthopedic perspective of osteoporosis
- Lessons from the bone histomorphometry on the mechanism of action of osteoporosis drugs
- Design considerations for clinical investigations of osteoporosis
- Regulatory considerations for the design and conduct of osteoporosis registration trials
- Evidence-based osteoporosis care
- The role of calcium in the treatment of osteoporosis
- Vitamin D and its metabolites and analogs in the management of osteoporosis
- Estrogen therapy: prevention and treatment of osteoporosis
- Estrogen analogues: selective estrogen receptor modulators and phytoestrogens
- Bisphosphonates: pharmacology and use in the treatment of osteoporosis
- Calcitonin in osteoporosis
- Strontium ranelate
- Androgens
- Treatment with PTH peptides
- Growth hormone and insulin-like growth factors: potential applications and limitations in the management of osteoporosis
- New approaches to osteoporosis therapeutics.